Shree Ganesh Remedies Ltd.

624.95 -4.85 ▼-0.8%

25 April 2024, 04:01:00 PM
Volume: 3,269

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ganeshremedies.com
Market Cap 802.89 Cr.
Enterprise Value(EV) 839.73 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 17.10 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 36.54 Trailing Twelve Months Ending 2023-12
Industry PE 41.30 Trailing Twelve Months Ending 2023-12
Book Value / Share 81.58 Trailing Twelve Months Ending 2023-12
Price to Book Value 7.66 Calculated using Price: 624.95
Dividend Yield 0.08 Period Ending 2023-03
No. of Shares Subscribed 1.28 Cr. 12,847,198 Shares
FaceValue 10
About Shree Ganesh Remedies Ltd.
The company is as ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

Shree Ganesh Remedies Ltd. Delivery

Delivered Qty
Traded Qty

Shree Ganesh Remedies Ltd. Performance

1 Day
-0.77%
1 Week
+6.47%
1 Month
-7.89%
3 Month
-9.11%
6 Month
+30.44%
1 Year
+103.73%
2 Year
+90.94%
5 Year
+1351.35%
10 Year

Shree Ganesh Remedies Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 10.38 8.06 17.31 20.75 19.95 25.35 21.18 24.02 22.62
Return on Capital Employed (%) 16.15 12.42 26.15 27.68 27.04 32.63 27.51 32.47 24.67
Return on Assets (%) 8.56 7.01 14.34 16.52 16.2 20.56 17.29 19.47 15.42

Shree Ganesh Remedies Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 13 14 17 29 34 42 50 62 89 100
Non Curr. Liab. 0 0 0 0 1 0 0 0 31 33
Curr. Liab. 2 2 4 7 7 10 10 15 24 23
Minority Int.
Equity & Liab. 15 16 21 36 41 52 61 77 144 156
Non Curr. Assets 5 5 5 7 16 17 23 32 79 89
Curr. Assets 10 11 17 28 26 35 38 45 64 67
Misc. Exp. not W/O
Total Assets 15 16 21 36 41 52 61 77 144 156

Shree Ganesh Remedies Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 17 16 20 27 35 58 49 71 90 117
Other Income 0 0 0 2 1 4 2 4 3 3
Total Income 17 16 20 29 36 63 51 75 93 121
Total Expenditure -14 -14 -16 -22 -27 -47 -35 -53 -67 -85
PBIDT 3 2 5 7 10 15 16 21 26 36
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -2 -3 -3 -4 -5
Taxation -1 -1 -1 -2 -2 -3 -3 -5 -6 -8
Exceptional Items
PAT 1 1 3 5 6 10 10 13 17 22
Adjusted EPS 1 1 3 4 5 8 8 11 14 18

Shree Ganesh Remedies Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 -5 4 3 13 17
Cash Fr. Inv. -3 0 -3 -1 -12 -54
Cash Fr. Finan. 8 0 0 -1 -1 41
Net Change 4 -5 1 2 0 5
Cash & Cash Eqvt 6 1 2 3 4 9

Shree Ganesh Remedies Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 69.12 69.12 68.27 68.27 69.33 69.33 69.33 69.33 69.33
Public 30.88 30.88 31.73 31.73 30.67 30.67 30.67 30.67 30.67
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Shree Ganesh Remedies Ltd. Announcements

Wed, 17 Apr 2024
Commencement Of Trial Run.
Commencement of Trial Run
Fri, 05 Apr 2024
Compliance Certificate Pursuant To Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended On March 31 2024
Compliance Certificate Pursuant to Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the year ended on March 31 2024
Fri, 05 Apr 2024
Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Year Ended On March 31 2024.
Certificate under Regulation 40 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for year ended on March 31 2024.

Shree Ganesh Remedies Ltd. Technical Scans

Wed, 24 Apr 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Shree Ganesh Remedies Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,140.18 1,520.15 +2.3%
Cipla Ltd. 112,292.49 1,406.20 +0.6%
Divi's Laboratories Ltd. 101,276.26 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. 99,314.42 6,218.75 +4.5%
Mankind Pharma Ltd. 95,586.41 2,398.55 +0.0%
Zydus Lifesciences Ltd. 93,730.70 951.25 +1.9%
Torrent Pharmaceuticals Ltd. 90,650.92 2,694.30 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.44 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.28 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 73.23 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 55.35 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.52 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.68 2,694.30 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.77 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.34 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 10.76 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.97 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.68 2,694.30 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,694.30 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,694.30 +0.3%

Shree Ganesh Remedies Ltd. FAQ's

What is Shree Ganesh Remed. share price?

Can I buy Shree Ganesh Remed. shares now?

What is the Dividend Yield of Shree Ganesh Remed.?

What is the Market Cap of Shree Ganesh Remed.?

What are the key metrics to analyse Shree Ganesh Remed.?

What is the 52 Week High and Low of Shree Ganesh Remed.?

What is the trend of Shree Ganesh Remed. share price?